Lymphatic Abnormalities
7
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (7)
A Prospective Natural History Study of Lymphatic Anomalies
Apple Peptide Complex for Post-Surgical and Aesthetic Skin Recovery
European Registry Study on Lymphatic Interventions
Institution of an Italian Registry and Biobank for Biological Sample Collection
Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training
Lymphatic Function in Patients With a Fontan Circulation From Brazil
Lymphatic Function in Patients With a Fontan-Kreutzer Circulation